Mandate

Vinge advises Pricer AB in connection with its issuance of senior unsecured bonds and early redemption

Vinge advises Pricer AB (publ) in connection with its issuance of floating rate senior unsecured bonds of SEK 300 million within a framework of SEK 500 million and early redemption of existing bonds.

The proceeds will be used to refinance Pricer’s existing bonds of SEK 250 million and to finance general corporate purposes, and the bonds will, in accordance with the terms and conditions, be listed on the corporate bond list of Nasdaq Stockholm. The bonds have a tenor of three years and carries an interest rate of STIBOR 3m + 400 basis points. In connection with the issuance, Pricer exercised its right to voluntary early redemption of the existing bonds.

Nordea Bank Abp has acted as sole bookrunner in the transaction.

Vinge’s team consisted of Albert Wållgren, Lionardo Ojeda, Calle Tengwall Pagels, William Carlberg Johansson, Nilufer Nouri (Banking and Finance), Dain Hård Nevonen and Benjamin Vafaeian (Capital Markets and Public M&A).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026